Literature DB >> 31054852

The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis.

Wei Liu1, Hong-Wei Wang1, Kun Wang2, Bao-Cai Xing3.   

Abstract

OBJECTIVE: Location of the primary tumor side has become an increasingly prognostic factor for colorectal liver metastasis. The present study was to perform a meta-analysis to investigate if primary right-sided tumor impacted on long-term survival outcome of colorectal liver metastases following local treatment.
METHOD: Eligible trials were identified from the Embase, PubMed, Web of Science and the Cochrane database that were published before October in 2018. English language trials that compared long-term survival outcome of primary left-sided tumor with right-sided tumor colorectal liver metastases following local treatment were included. Hepatic resection for colorectal liver metastases was investigated. The main study outcomes included overall survival and disease free survival of primary right-sided colorectal liver metastases following local treatment. The risk factors of largest tumor size, primary node metastases, multiple tumor and RAS mutation were also analyzed. A systematic review and meta-analysis was done using a fixed-effects model. Hazard ratio with a 95% confidence interval was used to measure the pooled effect.
RESULTS: A total of twelve studies with 6387 patients were included. For primary right-sided colorectal liver metastases patients following hepatic resection, the overall pooled HR for 5-year overall survival rate was 1.354 (95% CI: 1.238-1.482; p = 0.000; I2 = 33.7%, p = 0.138). The pooled HR for 5-year disease free survival rate of primary right-sided CRLM in the included studies calculated using the fix-effects model was 1.104 (95% CI: 0.987-1.235; p = 0.084; I2 = 0%, p = 0.477).
CONCLUSION: It demonstrated that primary right-sided for colorectal liver metastases location was a significantly worse prognostic factor in terms of overall survival.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Colorectal liver metastasis; Primary tumor; Side

Mesh:

Year:  2019        PMID: 31054852     DOI: 10.1016/j.ejso.2019.04.017

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  11 in total

Review 1.  The primary tumor location in colorectal cancer: A focused review on its impact on surgical management.

Authors:  Yuzo Nagai; Tomomichi Kiyomatsu; Yoshimasa Gohda; Kensuke Otani; Katsuya Deguchi; Kazuhiko Yamada
Journal:  Glob Health Med       Date:  2021-12-31

2.  Nomogram Predicting the Survival of Young-Onset Patients with Colorectal Cancer Liver Metastases.

Authors:  Xiaofei Cheng; Yanqing Li; Dong Chen; Xiangming Xu; Fanlong Liu; Feng Zhao
Journal:  Diagnostics (Basel)       Date:  2022-06-04

3.  PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION?

Authors:  Renato Gomes Campanati; João Bernardo Sancio; Lucas Mauro de Andrade Sucena; Marcelo Dias Sanches; Vivian Resende
Journal:  Arq Bras Cir Dig       Date:  2021-06-11

4.  Long-term Results of Surgery for Colorectal Liver Metastases in Terms of Primary Tumour Location and Clinical Risk Factors.

Authors:  Vladislav Treska; Martin Skala; Kristyna Prochazkova; Aneta Svejdova; Tereza Petrakova; Jakub Sebek; Ivan Riha; Jachym Rosendorf; Robert Polak; Tomas Skalicky; Vaclav Liska
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

5.  Preoperative nomogram to predict survival following colorectal cancer liver metastasis simultaneous resection.

Authors:  Qingying Meng; Nanxin Zheng; Rongbo Wen; Jinke Sui; Wei Zhang
Journal:  J Gastrointest Oncol       Date:  2021-04

6.  Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis-in vitro and in vivo.

Authors:  Yu-Shen Yang; Dan Wen; Xue-Feng Zhao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

7.  Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.

Authors:  Yuanping Zhang; Yongjin Wang; Yichuan Yuan; Jiliang Qiu; Yuxiong Qiu; Wei He; Yun Zheng; Zhiqiang Wang; Yangkui Gu; Zhenhai Lu; Gong Chen; Peirong Ding; Xiaojun Wu; Zhizhong Pan; Desen Wan; Yuhong Li; Ruihua Xu; Yunfei Yuan; Binkui Li
Journal:  World J Surg Oncol       Date:  2020-05-18       Impact factor: 2.754

8.  Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection.

Authors:  Ingrid Garajova; Rita Balsano; Chiara Tommasi; Raffaele Dalla Valle; Giuseppe Pedrazzi; Matteo Ravaioli; Andrea Spallanzani; Francesco Leonardi; Chiara Santini; Francesco Caputo; Mattia Riefolo; Mario Giuffrida; Fabio Gelsomino
Journal:  Acta Biomed       Date:  2020-12-01

9.  Effect of Chinese Herbal Medicine on the Survival of Colorectal Cancer Patients With Liver-Limited Metastases: A Retrospective Cohort Study, 2008 to 2017.

Authors:  Cui Shao; Qian Zuo; Jietao Lin; Rong Jian Yu; Yuanfeng Fu; Min Xiao; Ling Ling Sun; Lizhu Lin
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

10.  Preventive and therapeutic effect of intraportal oridonin on BALb/c nude mice hemispleen model of colon cancer liver metastasis.

Authors:  Yu-Shen Yang; Dan Wen; Xue-Feng Zhao
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.